Swiss Biotech Association appoints Nicolas Durand as CEO and Odile Rundquist as Chief Strategy & Growth Officer
The Swiss Biotech Association has appointed Nicolas Durand as CEO, effective January 1, 2027, and Odile Rundquist as Chief Strategy & Growth Officer, as of December 1, 2026. Nicolas Durand will assume overall executive responsibility for the association, while Odile Rundquist will focus on strategic development, partnerships, and access to capital. The association’s priorities remain unchanged: supporting its members and strengthening the Swiss biotech industry.
